WACKER Chemie secures global distribution rights for EVANIUM berberine ingredient

WACKER Chemie has obtained exclusive global distribution rights for EVANIUM's berberine ingredient, marketed as CAVABERINE® powered by OPTISOLV®, which uses a dual-coating delivery system with a cyclodextrin core and phospholipid shell. The ingredient is designed to improve berberine absorption and enable lower daily doses than the 1,000 to 1,500 mg typically required. WACKER will introduce the product at SupplySide Global in Las Vegas on October 28, starting its North American push, with the US as the primary focus in the first phase.

Key facts

Market context

Berberine is a plant-derived alkaloid long used in traditional medicine and now widely sold as a dietary supplement ingredient. Demand comes mainly from nutraceutical makers, where it is formulated into products aimed at blood sugar balance, weight management and general metabolic health, and from functional food developers. Berberine has a well-known drawback: its oral absorption is poor, so conventional products often require high daily doses. Ingredient suppliers therefore compete on bioavailability, since formulations that raise absorption can support lower doses, lower raw material use per serving and differentiated positioning. Delivery technologies such as cyclodextrin complexes and phospholipid-based carriers are common tools for this purpose. For buyers and investors, a distributor with broad reach can change competitive dynamics in the category by putting alternative grades in front of formulators that previously relied on standard berberine suppliers.

Source: official release on wacker.com. Summary and context written by Market Krystal.